Press Releases

New press releases will be uploaded soon.


Old Press Releases

CompuDrug Inc. signs agreement with Molcode Ltd.

August 12, 2005

CompuDrug, Inc., a niche software corporation that has been specializing in developing and generating ADME and drug discovery software for the past two decades, today announced that MolCode Ltd. has signed a software distribution agreement for the distribution of CodessaPRO (COmprehensive DEscriptors for Structural and Statistical Analysis). ...

Read the Pdf version of the newsletter


Practical applications of predictive ADME in modern drug design

March 24, 2005

The products of CompuDrug are pioneers in the field of predictive pharmaceutical and ADME software: the first predictive software was released in 1983. During the last two decades CompuDrug has become a well known developer of predictive software, and the Pallas ADME prediction expert system is used at several hundreds of pharmaceutical and biotechnological companies. This paper demonstrates some recent examples of the application of Pallas prediction engines in the field of drug discovery. Since hydrophobicity has an important role in drug development, the logP and logD predictions were utilized most extensively. ...

Read the Pdf version of the newsletter


KnowItAll ADME | Tox Software Recognized in R and D Magazine

August 10, 2004

Bio-Rad Laboratories, Inc. (AMEX BIO and BIOb), announced today that its KnowItAll® ADME/Tox software has been recognized as one of the 100 most technologically significant and innovative new products of 2004 by R&D magazine. The editors of R&D magazine, along with 50 outside experts, selected 100 products from all entrants worldwide based on the overall importance and uniqueness of their technology. ...

Read the Pdf version of the release:


ADME | Tox Informatics Product Differentiation Innovation Award from Frost and Sullivan

September 30, 2003

The Frost & Sullivan Product Differentiation Innovation Award is presented each year to the company that has best demonstrated the ability to develop and/or advance products with more innovative capabilities than competing vendors and products. This award recognizes the company´s successful adoption of new or existing technology that has become a part of its well-designed product family. ...

Read the Pdf version of the release:


ComGenex and CompuDrug form ADME | TOX Consensus Modeling Technical Board

August 12, 2003

Bio-Rad Laboratories, Inc. (AMEX: BIO and BIO.B), announced today the newest addition to its award-winning KnowItAll® Informatics System: the KnowItAll ADME/Tox Edition. This product is the first integrated desktop informatics solution for ADME/Tox evaluation and is the result of Bio-Rad´s collaboration with ComGenex, Inc. and CompuDrug International, Inc. ...

Read the Pdf version of the release


Bio-Rad Introduces Integrated ADME | TOX Informatics Solution

February 11, 2003

Bio-Rad Laboratories, Inc. (AMEX: BIO and BIO.B) announced today that ComGenex, Inc. and CompuDrug International, Inc. have joined with Bio-Rad Informatics as founding members of Bio-Rad´s ADME/Tox Consensus Modeling Technical Board. ...

Read the Pdf version of the release